Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
Other ingredients: Hypromellose (vegetable capsule), microcrystalline cellulose (plant fiber), magnesium stearate, silica
Practical convenience This is where oral delivery genuinely wins
Lancet 353 , 913 (1999)
By combining ApoD antibody and PBD as an ADC therapy, Takaya et al
Recombinant PCBP1 protein Recombinant human PCBP1 was purchased from MedChemExpress (HY-P74649, MedChemExpress)
US$ 23.70
US$ 25.90
US$ 20.44
US$ 27.26
US$ 24.91
US$ 28.42
US$ 24.51
